During the past decade, UCSF - San Francisco Gen Hosp conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCSF - San Francisco Gen Hosp" #1 sponsor was "University of California, San Francisco" with 11 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Glaxo Wellcome" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF - San Francisco Gen Hosp" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator and "Medical University of South Carolina" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "UCSF - San Francisco Gen Hosp" are "HIV Infections" (36 trials), "Cytomegalovirus Retinitis" (4 trials), "Herpes Simplex" (4 trials), "Sarcoma, Kaposi" (4 trials) and "Chronic Hepatitis" (2 trials). Many other conditions were trialed in "UCSF - San Francisco Gen Hosp" in a lesser frequency.

Most popular intervention types in "UCSF - San Francisco Gen Hosp" are "Drug" (40 trials), "Behavioral" (9 trials), "Other" (4 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Stavudine" (5 trials), "Nelfinavir mesylate" (4 trials), "Didanosine" (3 trials) and "Foscarnet sodium" (3 trials). Other intervention names were less common.

The vast majority of trials in "UCSF - San Francisco Gen Hosp" are 55 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "UCSF - San Francisco Gen Hosp". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in UCSF - San Francisco Gen Hosp, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UCSF - San Francisco Gen Hosp, 5 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 20 trials that are defined as “Not Applicable".